Product Specifications: Lyophilized Powder (>99% purity) in 3ml vial. *Requires Reconstitution ** Available for bulk custom order with 57 Cap/Crimp colors to choose from.
Application: Research peptide evaluated in strength building, anti-aging, metabolism, tissue repair
Chemical Formula: C165H269N47O46
CAS Number: 863288-34-0
Molecular Weight: ~3648.4 g/mol
Concentration: ≥99%
CJC-1295 with DAC (Drug Affinity Complex) is currently under investigation for multiple therapeutic applications, primarily centered around its role in growth hormone regulation. This synthetic analogue of growth hormone-releasing hormone (GHRH) is being studied for its potential benefits in several key areas of human health and performance.
Primary Research Applications
1. Muscle Development and Performance
- Focus on enhancement of muscle mass
- Investigation of strength improvement capabilities
- Mechanism linked to increased growth hormone secretion
2. Metabolic Effects
- Research into fat loss promotion
- Studies on lipolysis (fat breakdown) stimulation
- Potential implications for weight management
3. Skeletal Health
- Investigation of bone density enhancement
- Potential therapeutic value for osteoporosis prevention
- Research on fracture risk reduction
4. Tissue Repair
- Studies on wound healing acceleration
- Investigation of healing process enhancement
- Research on regenerative capabilities
5. Age-Related Applications
- Research on anti-aging properties
- Investigation of youth-preserving physiological effects
- Studies on growth hormone's role in aging processes
References:
Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism, 91(3), 799-805. https://doi.org/10.1210/jc.2005-2113
Ionescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism, 91(12), 4792-4797. https://doi.org/10.1210/jc.2006-1702
Alba, M., Fintini, D., Bowers, C. Y., Parlow, A. F., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290-E1294. https://doi.org/10.1152/ajpendo.00201.2006
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
